CD33 and acute lymphoblastic leukemia: To further confirm our cCAR’s independent antigen targeting ability, T-ALL Jurkat cell lines were overexpressed with either CD123 (Jurkatxp123) or CD33 (Jurkatxp33) and independent antigen expression was confirmed (Supplementary Fig. S1).